2026-01-17 23:04:01
Latest Post
Concord Control Systems Ltd receives order for IGBT based propulsion system for locomotive
RailTel Corporation of India Ltd receives order worth Rs. 12.28 crore
EIL to Expand Africa's Biggest Dangote Refinery
Mudunuru Ltd renews empanelment as System Integrator in BSNL Network
Reliance Retail Ventures Q3 FY26: Revenue ₹97,605 Crore, Up 8.1% YoY; 431 New Stores Added
Stock Report
Rossari Biotech Ltd Q3FY26 consolidated profit at Rs. 32.77 crores
Posted On : 2026-01-17 18:56:19( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended December 31, 2025.
Financial Results (Q3 FY2026) - QoQ Comparison
The company has reported total income of Rs. 582.189 crores during the period ended December 31, 2025 as compared to Rs. 587.711 crores during the period ended September 30, 2025.
The company has posted net profit / (loss) of Rs. 32.774 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 36.876 crores for the period ended September 30, 2025.
The company has reported EPS of Rs. 5.91 for the period ended December 31, 2025 as compared to Rs. 6.65 for the period ended September 30, 2025.
| Financials | Q3 FY2026 | Q2 FY2026 | % Change |
| Total Income | ₹ 582.189 crs | ₹587.711 crs |  -0.94% |
| Net Profit | ₹32.774 crs | ₹36.876 crs | -11.12% |
| EPS | ₹5.91 | ₹6.65 | -11.13% |
Financial Results (Q3 FY2026) - YoY Comparison
The company has reported total income of Rs. 582.189 crores during the period ended December 31, 2025 as compared to Rs.513.282 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.32.774 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.31.702 crores for the period ended December 31, 2024.
The company has reported EPS of Rs.5.91 for the period ended December 31, 2025 as compared to Rs.5.72 for the period ended December 31, 2024.
| Financials | Q3 FY2026 | Q3 FY2025 | % Change |
| Total Income | ₹ 582.189 crs | ₹513.282 crs |  13.42% |
| Net Profit | ₹32.774 crs | ₹31.702 crs | 3.38% |
| EPS | ₹5.91 | ₹5.72 | 3.32% |
Financial Results (9 Months Ended FY2026) - YoY Comparison
The company has reported total income of Rs.1714.816 crores during the 9 Months period ended December 31, 2025 as compared to Rs.1502.950 crores during the 9 Months period ended December 31, 2024.
The company has posted net profit / (loss) of Rs.103.246 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.101.934 crores for the 9 Months period ended December 31, 2024.
The company has reported EPS of Rs.18.63 for the 9 Months period ended December 31, 2025 as compared to Rs.18.41 for the 9 Months period ended December 31, 2024.
| Financials | 9 Months Ended FY2026 | 9 Months Ended FY2025 | % Change |
| Total Income | ₹1714.816 crs | ₹1502.950 crs | 14.10% |
| Net Profit | ₹103.246 crs | ₹101.934 crs | 1.29% |
| EPS | ₹18.63 | ₹18.41 | 1.20% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 534.65 as compared to the previous close of Rs. 540.00. The total number of shares traded during the day was 1276 in over 146 trades.
The stock hit an intraday high of Rs. 542.90 and intraday low of 534.00. The net turnover during the day was Rs. 685975.00.
